Gene Predictis SA, a Swiss precision medicine company offering tools to optimize drug treatments, is a winner of the European Venture Contest 2015. The company was selected from over 1’000 companies in high technology sector, by an international investors jury composed of over 100 investors and business angels, based on its technology and business opportunity, as […]
Gene Predictis®, a Swiss precision medicine company, announces the closing of its first financing round. The company has raised CHF 0.5 million from a strategic investor that is a major player in the Swiss health care ecosystem. The proceeds will be used to support marketing and commercialization in Switzerland of its leading product, Pill Protect®, […]
Gene Predictis®, a Swiss precision medicine company, has completed an international clinical validation study for Pill Protect®, an innovative medical test that uses genetic data to identify women at risk of developing blood clots (thrombosis) when using contraceptive pills. The test was shown to identify over 8 times more women at risk than today standard […]
Gene Predictis is a winner of the 2015 Alpine High-tech Venture Forum Award. The company was selected by an international investors jury, based on its technology and business opportunity, as one of the most promising companies in the Life Sciences field. Organised by Europe Unlimited and supported by Eureka High-Tech Investment Programme and Canton de Vaud, The […]
Gene Preditis has been awarded the CTI Start-Up Label on September 10th, 2013 by the Commission for Technology and Innovation CTI, Swiss Confederation. The Start-up Label is a seal of quality, a certificate of achievement, and a sign of credibility and readiness for sustainable growth.
We are happy to share with you our recent press release: Bilan Startupticker.ch
In August 2012, Gene Predictis SA moved its headquarters and laboratories to the Science Park EPFL in Lausanne. Today, we have a pleasure to inaugurate our new space and present you our products.
We have recently discovered that our company name and registered trademark GENE PREDICTIS are used by third parties without our consent and associated to products and services which have nothing to do with Gene Predictis SA. In addition, misleading photographs of our partners, locations, collaborators and clinics are used without prior consent. We are currently […]